Q301--REFERENCE LAB TESTING

The Department of Veterans Affairs, Network Contracting Office 16, issued an amendment (Standard Form 30, Amendment/Modification of Contract) to Solicitation Number 36C25626Q0367 for the Alexandria VA Health Care System. The primary purpose of this amendment is to extend the closing date and hour for the receipt of offers. The original closing date of March 6, 2026, at 1:00 PM (CST) has been extended to March 13, 2026, at 4:30 PM (CDT). Offerors must acknowledge receipt of this amendment to ensure their offers are considered. This modification, signed by Contracting Officer Arlene A. Blade, ensures all potential bidders have additional time to submit their proposals.

This Combined Synopsis/Solicitation Notice (RFQ 36C25626Q0367) by the Department of Veterans Affairs seeks a contractor to provide specialized reference laboratory testing services for the Central Arkansas Veterans Healthcare System. The objective is to secure high-quality, timely, and accurate diagnostic testing that cannot be performed in-house or through "pass-through" arrangements due to concerns about specimen integrity and turnaround times. The contract is for a Firm-Fixed Priced Open-Market Blanket Purchase Agreement, with a performance period from April 1, 2026, to March 31, 2031, including a base year and four option periods. The solicitation specifies a wide range of tests, including molecular detections, antibody assays, and various diagnostic evaluations. Key requirements include stringent quality control, secure data management compliant with HIPAA, and adherence to VA information security and records management policies. Quotes are due by March 6, 2026, at 1:00 P.M. Central Time.

The document outlines a multi-year contract for various medical diagnostic tests and evaluations, covering a base period from March 1, 2026, to February 28, 2027, and two optional periods from April 1, 2027, to March 31, 2028, and April 1, 2028, to March 31, 2029. The services include a wide range of specialized tests such as Adenovirus DNA Detection, Amylase, Pancreatic Cyst Fluid, various Anti-Glial/Neuronal Nuclear Antibody tests, Amphiphysin Antibody tests, Aspergillus Antigen detection, Biliary Tract Malignancy FISH and cytology, Carcinoembryonic Antigen, Cytomegalovirus Molecular Detection, Meningitis/Encephalitis Pathogen Panel, and numerous other neurological, immunological, and infectious disease diagnostics. Each item specifies the description, contract period, and quantity. The repetition of items across the base and option periods indicates a consistent need for these diagnostic services over several years.

This government file outlines a Past Performance Questionnaire/Evaluation Factor designed for assessing contractor performance in federal procurement. The questionnaire is used to evaluate offerors based on their past contracts, focusing on key areas such as courier services (professionalism, adherence to schedules, specimen handling), quality and timeliness of testing (meeting turnaround times, reporting critical values), effectiveness of customer service (supply provision, account representative responsiveness, issue resolution), and success in establishing electronic ordering and reporting interconnections. It includes a rating system (Excellent, Very Good, Satisfactory, Poor) and prompts for detailed comments, contractor failures, and willingness to re-award contracts. The document also specifies a return deadline, contact information, and clarifies that contractors may be advised of adverse remarks but will not receive copies of the questionnaire or evaluators' names, in accordance with Federal Acquisition Regulations.